EP3830125 - CHIMERIC ANTIGEN RECEPTOR THERAPY T CELL EXPANSION KINETICS AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.05.2021 Database last updated on 15.06.2024 | |
Former | The international publication has been made Status updated on 08.02.2020 | ||
Former | unknown Status updated on 06.09.2019 | Most recent event Tooltip | 12.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Kite Pharma, Inc. 2400 Broadway Santa Monica, CA 90404 / US | [2021/23] | Inventor(s) | 01 /
ROSSI, John M. c/o Kite Pharma, Inc. 2400 Broadway Santa Monica, California 90404 / US | 02 /
BOT, Adrian I. c/o Kite Pharma, Inc. 2400 Broadway Santa Monica, California 90404 / US | [2021/23] | Representative(s) | Schnappauf, Georg ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2021/23] | Application number, filing date | 19759453.4 | 01.08.2019 | [2021/23] | WO2019US44638 | Priority number, date | US201862713994P | 02.08.2018 Original published format: US 201862713994 P | US201862756391P | 06.11.2018 Original published format: US 201862756391 P | [2021/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020028647 | Date: | 06.02.2020 | Language: | EN | [2020/06] | Type: | A1 Application with search report | No.: | EP3830125 | Date: | 09.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.02.2020 takes the place of the publication of the European patent application. | [2021/23] | Search report(s) | International search report - published on: | EP | 06.02.2020 | Classification | IPC: | C07K16/28, A61K35/17, A61K39/00, C07K14/725, G01N33/50 | [2021/23] | CPC: |
C07K16/2803 (EP,IL);
A61K35/17 (IL,US);
C12N5/0636 (EP,IL,KR,US);
A61K39/4611 (EP,IL,KR);
A61K39/4631 (EP,IL,KR);
A61K39/464412 (EP,IL,KR);
A61P35/00 (KR);
C07K14/7051 (EP,IL);
G01N33/57426 (EP,IL,KR);
C07K2317/622 (EP,IL,KR);
C07K2319/03 (EP,IL);
C07K2319/33 (EP,IL);
C12N2501/2301 (KR);
C12N2501/2302 (EP,IL,US);
C12N2510/00 (EP,IL,KR);
G01N2800/52 (EP,IL,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/23] | Title | German: | T-ZELL-EXPANSIONSKINETIK FÜR CHIMÄRE ANTIGEN-REZEPTORTHERAPIE UND IHRE VERWENDUNGEN | [2021/23] | English: | CHIMERIC ANTIGEN RECEPTOR THERAPY T CELL EXPANSION KINETICS AND USES THEREOF | [2021/23] | French: | CINÉTIQUE D'EXPANSION DE LYMPHOCYTES T POUR THÉRAPIE PAR RÉCEPTEUR D'ANTIGÈNE CHIMÉRIQUE ET SES UTILISATIONS | [2021/23] | Entry into regional phase | 28.01.2021 | National basic fee paid | 28.01.2021 | Designation fee(s) paid | 28.01.2021 | Examination fee paid | Examination procedure | 28.01.2021 | Amendment by applicant (claims and/or description) | 28.01.2021 | Examination requested [2021/23] | 28.01.2021 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 13.08.2021 | Renewal fee patent year 03 | 15.06.2022 | Renewal fee patent year 04 | 14.06.2023 | Renewal fee patent year 05 | 12.06.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XYI]US2016303166 (KATZ STEVEN C [US], et al); | [X]US2017137783 (BEDOYA FELIPE [US], et al); | [X]US2018022815 (CHANG LUNG-JI [US]); | [X]WO2018132695 (CELDARA MEDICAL LLC [US], et al); | [XY]US2018208671 (WANG QIONG J [US], et al); | by applicant | US5728388 | US5827642 | US6040177 | US6319494 | US2002006409 | US6797514 | US6867041 | US6905874 | WO2008081035 | US7741465 | WO2012079000 | WO2012129514 | US2013287748 | US2014050708 | US2014099309 | US2014154228 | US2014227237 | US19430622621 | US19500621677 |